Kiley Juergens Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Kiley Juergens Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$371K	Buy	+2,902	New	+$362K	0.07%	158

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Kiley Juergens Wealth Management's XBI Position: Q1 2026 in Review

Kiley Juergens Wealth Management opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q1 2026: 2,902 shares worth $371K. The stake represents 0.07% of the portfolio and ranks #158 among its holdings.

813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Kiley Juergens Wealth Management held 2,902 shares of State Street SPDR S&P Biotech ETF worth $371K as of Q1 2026.
State Street SPDR S&P Biotech ETF was a new Kiley Juergens Wealth Management position in Q1 2026.
State Street SPDR S&P Biotech ETF made up 0.07% of Kiley Juergens Wealth Management's portfolio in Q1 2026, its #158 holding.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Kiley Juergens Wealth Management's 13F filing for Q1 2026, filed 28 Apr 2026.